People
The U.S. Senate confirmed Hahn as the new commissioner Thursday in a 72-18 vote.
House Speaker Nancy Pelosi’s drug pricing reform bill passed the House of Representatives in a mostly party-line vote and will now head to the U.S. Senate, where its chances of moving forward in the Republican-led chamber are slim.
Inceptua announced that Stefan Fraenkel has been appointed CEO effective 1 January 2020.
Pharma and biotech companies strengthen their leadership teams and boards with this week’s hires.
Karuna’s work is primarily focused on psychosis related to schizophrenia and late-stage Alzheimer’s disease, as well as analgesic effects for pain.
Aligos Chief Executive Officer Lawrence Blatt told BioSpace that the different assets in development address different components of the infection.
At the six-year mark, 90.6% of patients in the Perjeta cohort have not had breast cancer return, compared to 87.8% in the placebo arm. This comes to an absolute benefit of 2.8%.
Dr. Spychala Brings Patient-Centricity and Rare Disease Clinical Research Expertise to New Role
Locana, Inc., a leading RNA-targeting gene therapy company, announced the appointment of James Burns, Ph.D., as chief executive officer, as a key step in expanding the experienced leadership team and as part of a planned transition of the company’s director and recent CEO, Jeffrey M. Ostrove, Ph.D., to continue service as director..
BioArctic AB will be strengthening its management team in 2020 through two strategic recruitments.
PRESS RELEASES